Johnson & Johnson (JNJ) Raw Materials (2012 - 2018)
Johnson & Johnson's (JNJ) quarterly Raw Materials came in at $1.1 billion in Q4 2018, down 2.28% year-over-year from $1.1 billion in Q4 2017, and down 7.32% quarter-over-quarter from $1.2 billion in Q3 2018.
Analysis
Johnson & Johnson (JNJ) Raw Materials (2012 - 2018) Analysis & Trends
Johnson & Johnson has disclosed Raw Materials across 6 years of filings, most recently posting $1.1 billion for Q4 2018.
- In Q4 2018, Raw Materials fell 2.28% year-over-year to $1.1 billion; the TTM figure through Dec 2018 stood at $1.1 billion (down 2.28% YoY), while the FY2018 annual figure was $1.1 billion, down 2.28% from the prior year.
- Raw Materials came in at $1.1 billion for Q4 2018 at Johnson & Johnson, down from $1.2 billion in the prior quarter.
- In the past five years, Raw Materials ranged from a high of $1.2 billion in Q4 2014 to a low of $936.0 million in Q1 2016.
- Average Raw Materials over 4 years is $1.1 billion, with a median of $1.1 billion recorded in 2017.
- Year-over-year, Raw Materials retreated 22.9% in 2016 and advanced 19.75% in 2017.
- Over 4 years, Raw Materials stood at $1.2 billion in 2014, then fell by 22.9% to $936.0 million in 2016, then climbed by 21.79% to $1.1 billion in 2017, then retreated by 2.28% to $1.1 billion in 2018.
- Per Business Quant data, the three most recent Raw Materials figures were $1.1 billion in Q4 2018, $1.2 billion in Q3 2018, and $1.2 billion in Q3 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn |
| 10 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 30, 2018 | 1.11 Bn |
| Sep 30, 2018 | 1.20 Bn |
| Jul 1, 2018 | 1.17 Bn |
| Dec 31, 2017 | 1.14 Bn |
| Jan 1, 2017 | 952.00 Mn |
| Jan 3, 2016 | 936.00 Mn |
| Dec 28, 2014 | 1.21 Bn |
| Dec 29, 2013 | 1.22 Bn |
| Dec 30, 2012 | 1.42 Bn |
| Jan 1, 2012 | 1.21 Bn |